Artículos por temáticas

The therapeutic role of cannabinoid receptors and its agonists or antagonists in Parkinson's disease

Han QW, Yuan YH, Chen NH.

Prog Neuropsychopharmacol Biol Psychiatry. 2020 Jan 10;96:109745. doi: 10.1016/j.pnpbp.2019.109745. Epub 2019 Aug 20.

Neuroprotection and immunomodulation of progesterone in the gut of a mouse model of Parkinson's disease

Jarras H, Bourque M, Poirier AA, Morissette M, Coulombe K, Di Paolo T, Soulet D.

J Neuroendocrinol. 2020 Jan;32(1):e12782. doi: 10.1111/jne.12782. Epub 2019 Sep 10.

Early Postnatal Exposure to Paraquat and Maneb in Mice Increases Nigrostriatal Dopaminergic Susceptibility to a Re-challenge with the Same Pesticides at Adulthood: Implications for Parkinson's Disease

Colle D, Santos DB, Naime AA, Gonçalves CL, Ghizoni H, Hort MA, Farina M.

Neurotox Res. 2020 Jan;37(1):210-226. doi: 10.1007/s12640-019-00097-9. Epub 2019 Aug 17.

The Interaction Between Neuroinflammation and β-Amyloid in Cognitive Decline in Parkinson's Disease

Ghadery C, Koshimori Y, Christopher L, Kim J, Rusjan P, Lang AE, Houle S, Strafella AP.

Mol Neurobiol. 2020 Jan;57(1):492-501. doi: 10.1007/s12035-019-01714-6. Epub 2019 Aug 5.

Carvacrol Protects Against 6-Hydroxydopamine-Induced Neurotoxicity in In Vivo and In Vitro Models of Parkinson's Disease

Manouchehrabadi M, Farhadi M, Azizi Z, Torkaman-Boutorabi A.

Neurotox Res. 2020 Jan;37(1):156-170. doi: 10.1007/s12640-019-00088-w. Epub 2019 Jul 30.

Distinct subthalamic coupling in the ON state describes motor performance in Parkinson's disease

Ozturk M, Abosch A, Francis D, Wu J, Jimenez-Shahed J, Ince NF.

Mov Disord. 2020 Jan;35(1):91-100. doi: 10.1002/mds.27800. Epub 2019 Jul 26.

Emergencies in an Advanced Stage Parkinson's Disease Patient

Boulas KA, Paraskeva A, Hatzigeorgiadis A.

Gastroenterology. 2020 Jan;158(1):e1-e2. doi: 10.1053/j.gastro.2019.07.023. Epub 2019 Jul 18.

Progressive brain atrophy in Parkinson's disease patients who convert to mild cognitive impairment

Zhou C, Guan XJ, Guo T, Zeng QL, Gao T, Huang PY, Xuan M, Gu QQ, Xu XJ, Zhang MM.

CNS Neurosci Ther. 2020 Jan;26(1):117-125. doi: 10.1111/cns.13188. Epub 2019 Jul 6.

Sleep in Parkinson's disease

Stefani A, Högl B.

Neuropsychopharmacology. 2020 Jan;45(1):121-128. doi: 10.1038/s41386-019-0448-y. Epub 2019 Jun 24.

Greater intraindividual variability in neuropsychological performance predicts cognitive impairment in de novo Parkinson's disease

Jones JD, Burroughs M, Apodaca M, Bunch J.

Neuropsychology. 2020 Jan;34(1):24-30. doi: 10.1037/neu0000577. Epub 2019 Jun 20.

Parkinsonism.

Shrimanker I, Tadi P, Sánchez-Manso JC.

2019 Jun 4. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan-.

Joint-Connectivity-Based Sparse Canonical Correlation Analysis of Imaging Genetics for Detecting Biomarkers of Parkinson's Disease

Kim M, Won JH, Youn J, Park H.

IEEE Trans Med Imaging. 2020 Jan;39(1):23-34. doi: 10.1109/TMI.2019.2918839. Epub 2019 May 24.

Does the M.D. Anderson Dysphagia Inventory correlate with dysphagia-limit and the Unified Parkinson Disease Rating Scale in early-stage Parkinson's disease?

Wang CM, Tsai TT, Wang SH, Wu YR.

J Formos Med Assoc. 2020 Jan;119(1 Pt 2):247-253. doi: 10.1016/j.jfma.2019.05.005. Epub 2019 May 24.

Management of Dysphagia in Patients with Parkinson's Disease and Related Disorders.

Umemoto G, Furuya H.

Intern Med. 2020 Jan 1;59(1):7-14. doi: 10.2169/internalmedicine.2373-18. Epub 2019 Apr 17.

Cognitive profiles and optimal cut-offs for routine cognitive tests in elderly individuals with Parkinson's disease, Parkinson's disease dementia, Alzheimer's disease, and normal cognition.

Phannarus H, Muangpaisan W, Siritipakorn P, Chotinaiwattarakul W.

Psychogeriatrics. 2020 Jan;20(1):20-27. doi: 10.1111/psyg.12451. Epub 2019 Mar 25.